QR Code

Effect of denosumab on glucose metabolism in postmenopausal osteoporotic women with prediabetes: a study protocol for a 12-month multicenter, open-label, randomized controlled trial

Abstract Background Participants with prediabetes are at a high risk of developing type 2 diabetes (T2D). Recent studies have suggested that blocking the receptor activator of nuclear factor-κB ligand (RANKL) may improve glucose metabolism and delay the development of T2D. However, the effect of den...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Yilin Wang, Yu Jiang, Jia Li, Xisheng Lin, Yan Luo, Shuhuai Tan, Haohan Yang, Zefu Gao, Xiang Cui, Pengbin Yin, Dan Kong, Yuan Gao, Yu Cheng, Licheng Zhang, Peifu Tang, Houchen Lyu
Hōputu: Artigo
Reo:Inglês
I whakaputaina: BMC 2023-12-01
Rangatū:Trials
Ngā marau:
Denosumab
Glucose metabolism
Osteoporosis
Postmenopausal women
Prediabetes
RANKL
Urunga tuihono:https://doi.org/10.1186/s13063-023-07769-0
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite